Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Päivä, Hannu
15  Ergebnisse:
Artikel (Online) X
Personensuche X
?
1

Beyond LDL-C lowering: Distinct molecular sphingolipids are..:

Jänis, Minna T. ; Tarasov, Kirill ; Ta, Hung Xuan...
Atherosclerosis.  228 (2013)  2 - p. 380-385 , 2013
Link: https://doi.org/10.1016/..
 
?
2

Molecular Lipids Provide More Information on PCSK9 Deficien..:

Laaksonen, Reijo ; Tarasov, Kirill ; Ta, Hung Xuan...
Journal of Clinical Lipidology.  6 (2012)  3 - p. 284 , 2012
Link: https://doi.org/10.1016/..
 
?
3

Levels of asymmetrical dimethylarginine are predictive of b..:

Päivä, Hannu ; Kähönen, Mika ; Lehtimäki, Terho...
Atherosclerosis.  212 (2010)  2 - p. 512-515 , 2010
Link: https://doi.org/10.1016/..
 
?
4

Plasma asymmetric dimethylarginine and retinal vessel diame..:

Hemminki, Virpi ; Laakso, Juha ; Kähönen, Mika...
Metabolism.  56 (2007)  10 - p. 1305-1310 , 2007
Link: https://doi.org/10.1016/..
 
?
5

A Systems Biology Strategy Reveals Biological Pathways and ..:

Laaksonen, Reijo ; Katajamaa, Mikko ; Päivä, Hannu...
PLoS ONE.  1 (2006)  1 - p. e97 , 2006
Link: https://doi.org/10.1371/..
 
?
6

Plasma asymmetric dimethylarginine (ADMA), nitrate and the ..:

Päivä, Hannu ; Laakso, Juha ; Ruokonen, Inkeri...
Clinica Chimica Acta.  371 (2006)  1-2 - p. 97-101 , 2006
Link: https://doi.org/10.1016/..
 
?
7

High‐Dose Statin Treatment Does Not Alter Plasma Marker for..:

Thelen, Karin M. ; Laaksonen, Reijo ; Päivä, Hannu..
The Journal of Clinical Pharmacology.  46 (2006)  7 - p. 812-816 , 2006
Link: https://doi.org/10.1177/..
 
?
8

Asymmetric dimethylarginine and hemodynamic regulation in m..:

Päivä, Hannu ; Laakso, Juha ; Kähönen, Mika...
Metabolism.  55 (2006)  6 - p. 771-777 , 2006
Link: https://doi.org/10.1016/..
 
?
9

Genetic variant of the SREBF-1 gene is significantly relate..:

Laaksonen, Reijo ; Thelen, Karin M ; Päivä, Hannu...
Atherosclerosis.  185 (2006)  1 - p. 206-209 , 2006
Link: https://doi.org/10.1016/..
 
?
10

Dietary composition as a determinant of plasma asymmetric d..:

Päivä, Hannu ; Lehtimäki, Terho ; Laakso, Juha...
Metabolism.  53 (2004)  8 - p. 1072-1075 , 2004
Link: https://doi.org/10.1016/..
 
?
11

Asymmetrical dimethylarginine (ADMA) and risk of acute coro..:

Valkonen, Veli-Pekka ; Laakso, Juha ; Päivä, Hannu...
Atherosclerosis Supplements.  4 (2003)  4 - p. 19-22 , 2003
Link: https://doi.org/10.1016/..
 
?
12

Effect of High-Dose Statin Treatment on Plasma Concentratio..:

Päivä, Hannu ; Laakso, Juha ; Lehtimäki, Terho...
Journal of Cardiovascular Pharmacology.  41 (2003)  2 - p. 219-222 , 2003
Link: https://doi.org/10.1097/..
 
?
13

Plasma concentrations of asymmetric-dimethyl-arginine in ty..:

Päivä, Hannu ; Lehtimäki, Terho ; Laakso, Juha...
Metabolism.  52 (2003)  3 - p. 303-307 , 2003
Link: https://doi.org/10.1053/..
 
?
14

FT-IR Breath Test in the Diagnosis and Control of Treatment..:

Laakso, Olli ; Haapala, Matti ; Jaakkola, Petri...
Journal of Analytical Toxicology.  25 (2001)  1 - p. 26-30 , 2001
Link: https://doi.org/10.1093/..
 
?
15

Functional cerebral imaging in the evaluation and radiother..:

Pardo, Francisco S. ; Aronen, Hannu J. ; Kennedy, David...
International Journal of Radiation Oncology*Biology*Physics.  30 (1994)  3 - p. 663-669 , 1994
Link: https://doi.org/10.1016/..
 
1-15